Intravenous Compared to Oral Busulfan with Cyclophosphamide for Autologous Hematopoietic Progenitor Cell Transplant Conditioning for Plasma Cell Myeloma

被引：0
|
作者：
Sobecks, Ronald [1 ]
Rybicki, Lisa [2 ]
Dean, Robert M. [1 ]
Abounader, Donna [1 ]
Andresen, S. [1 ]
Hien Duong [1 ]
Reu, Fred [1 ]
Bolwell, Brian [1 ]
Copelan, Ed [1 ]
Kalaycio, Matt E. [1 ]
机构：
[1] Cleveland Clin, Taussig Canc Inst, Dept Hematol Oncol & Blood Disorders, Cleveland, OH 44106 USA
[2] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2013年 / 19卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2012.11.192
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
152
引用
收藏
页码：S190 / S190
页数：1
相关论文
共 50 条
  • [1] Intravenous Compared to Oral Busulfan with Cyclophophamide for Allogeneic Hematopoietic Progenitor Cell Transplant Conditioning for AML and MDS
    Sobecks, Ronald
    Rybicki, Lisa
    Kalaycio, Matt
    Dean, Robert
    Andresen, Steven
    Pohlman, Brad
    Bolwell, Brian J.
    Copelan, Edward A.
    BLOOD, 2010, 116 (21) : 1427 - 1428
  • [2] Application of the Conditioning Regimen with Busulfan and Cyclophosphamide in Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
    Xu, Yun
    Yao, Ying
    Yao, Weiqin
    Jin, Song
    Yan, Lingzhi
    Shang, Jingjing
    Fu, Chengcheng
    Wu, Depei
    BLOOD, 2017, 130
  • [3] APPLICATION OF CONDITIONING REGIMEN WITH BUSULFAN AND CYCLOPHOSPHAMIDE IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA
    Xu, Y.
    Fu, C.
    Yao, Y.
    Yao, W.
    Jin, S.
    Yan, L.
    Shang, J.
    Zhu, X.
    Sun, A.
    Wu, D.
    HAEMATOLOGICA, 2017, 102 : 787 - 787
  • [4] Intravenous busulfan with thiotepa and cyclophosphamide (TBC) as a conditioning regimen for autologous progenitor cell transplantation (PCT) in patients with multiple myeloma (MM).
    Anagnostopoulos, A
    Aleman, A
    Weber, D
    Andersson, B
    Braunschweig, I
    Claxton, D
    Donato, M
    Khouri, I
    Anderlini, P
    Korbling, M
    Gajewski, J
    Alexanian, R
    Champlin, R
    Giralt, S
    BLOOD, 1999, 94 (10) : 335A - 335A
  • [5] Intravenous compared with oral busulfan as preparation for allogeneic hematopoietic progenitor cell transplantation for AML and MDS
    Sobecks, R. M.
    Rybicki, L.
    Yurch, M.
    Kalaycio, M.
    Dean, R.
    Andresen, S.
    Pohlman, B.
    Duong, H.
    Bolwell, B.
    Copelan, E.
    BONE MARROW TRANSPLANTATION, 2012, 47 (05) : 633 - 638
  • [6] Intravenous compared with oral busulfan as preparation for allogeneic hematopoietic progenitor cell transplantation for AML and MDS
    R M Sobecks
    L Rybicki
    M Yurch
    M Kalaycio
    R Dean
    S Andresen
    B Pohlman
    H Duong
    B Bolwell
    E Copelan
    Bone Marrow Transplantation, 2012, 47 : 633 - 638
  • [7] Busulfan, cyclophosphamide, and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma
    Cogle, CR
    Moreb, JS
    Leather, HL
    Finiewicz, KJ
    Khan, SA
    Reddy, VS
    Wingard, JR
    AMERICAN JOURNAL OF HEMATOLOGY, 2003, 73 (03) : 169 - 175
  • [8] Busulfan,cyclophosphamide and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma
    张春阳
    China Medical Abstracts(Internal Medicine), 2013, 30 (02) : 116 - 117
  • [9] Pharmacogenetics of Intravenous and Oral Busulfan in Hematopoietic Cell Transplant Recipients
    Abbasi, Nissa
    Vadnais, Barbara
    Knutson, Jennifer A.
    Blough, David K.
    Kelly, Edward J.
    O'Donnell, Paul V.
    Deeg, H. Joachim
    Pawlikowski, Matthew A.
    Ho, Rodney J. -Y.
    McCune, Jeannine S.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (10): : 1429 - 1438
  • [10] High dose busulfan, cyclophosphamide and etoposide as a conditioning regimen for autologous progenitor cell transplantation in patients with multiple myeloma.
    Cogle, CR
    Moreb, JS
    Belanger, GL
    Leather, HL
    Boyette, RM
    Finiewicz, K
    Khan, SA
    Reddy, VS
    Wingard, JR
    BLOOD, 2000, 96 (11) : 368B - 368B
12345